Newpath Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Createcreatemedicines.comin𝕏Nov 2022
CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Daniel Getts(Founder and CEO)inBrett Kaplan(Chief Financial and Business Officer)inMarcus Lowe(Executive Officer, Director)Dhruv Amin(Executive Officer, Director)
Co-investors8VCRaptor Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.